Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACADIA Pharmaceuticals Inc (ACAD) -- Ignore unavailable to you. Want to Upgrade?

To: dr.praveen who wrote (392)	3/19/2007 2:53:33 PM
From: mopgcw	Respond to of 588

fwiw, i am taking profits on 1/2, will hold a small position for further excitement....

To: dr.praveen who wrote (392)	3/19/2007 3:01:07 PM
From: Ian@SI	Read Replies (1) \| Respond to of 588

Dr. P., Congrats on your realized profit. With just under 30M shares outstanding (float about 25M), today's Mkt Cap at the moment is about $400M up from $210M on Friday. If I can look at Zyprexa sales as a benchmark, ACP103 could well have peak sales of somewhere near $2B-$4B implying a mkt cap of up to $12B - a 30 bagger from here. Even if we look at peak sales of $1.5B, that implies a 10-bagger for ACAD from today's price. Do you not have confidence in a successful PhIII any time soon? or is there some other reason for the sale? I too have a very small position which got established when the 10 contracts I didn't buy back got assigned to me on Saturday. I'm leaning toward holding the shares, so I'm quite interested in your views. Thanks, Ian